159 related articles for article (PubMed ID: 15668751)
1. Alefacept is well tolerated in patients with chronic plaque psoriasis.
Gottlieb AB
J Cutan Med Surg; 2004 Dec; 8 Suppl 2():14-9. PubMed ID: 15668751
[TBL] [Abstract][Full Text] [Related]
2. An integrated analysis of thirteen trials summarizing the long-term safety of alefacept in psoriasis patients who have received up to nine courses of therapy.
Goffe B; Papp K; Gratton D; Krueger GG; Darif M; Lee S; Bozic C; Sweetser MT; Ticho B
Clin Ther; 2005 Dec; 27(12):1912-21. PubMed ID: 16507377
[TBL] [Abstract][Full Text] [Related]
3. Alefacept: a review of the literature and practical guidelines for management.
Hodak E; David M
Dermatol Ther; 2004; 17(5):383-92. PubMed ID: 15379773
[TBL] [Abstract][Full Text] [Related]
4. Clinical update on alefacept: consideration for use in patients with psoriasis.
Gade JN
J Manag Care Pharm; 2004 Jun; 10(3 Suppl B):S33-7. PubMed ID: 15253688
[TBL] [Abstract][Full Text] [Related]
5. Selective targeting of T cell subsets: focus on alefacept - a remittive therapy for psoriasis.
Krueger GG
Expert Opin Biol Ther; 2002 Apr; 2(4):431-41. PubMed ID: 11955280
[TBL] [Abstract][Full Text] [Related]
6. Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes.
Ellis CN; Krueger GG;
N Engl J Med; 2001 Jul; 345(4):248-55. PubMed ID: 11474662
[TBL] [Abstract][Full Text] [Related]
7. Repeat courses of intravenous alefacept in patients with chronic plaque psoriasis provide consistent safety and efficacy.
Lowe NJ; Gonzalez J; Bagel J; Caro I; Ellis CN; Menter A
Int J Dermatol; 2003 Mar; 42(3):224-30. PubMed ID: 12653922
[TBL] [Abstract][Full Text] [Related]
8. Alefacept for chronic plaque psoriasis: a selective therapy with long-lasting disease remissions and an encouraging safety profile.
Leone G; Rolston K; Spaulding G
Dermatol Nurs; 2003 Jun; 15(3):216-20, 224-5; quiz 226. PubMed ID: 12875010
[TBL] [Abstract][Full Text] [Related]
9. Open-label, single-center, safety dose escalation trial of alefacept for the treatment of moderate to severe chronic plaque psoriasis.
Moul DK; Routhouska SB; Korman NJ
J Cutan Med Surg; 2007; 11(4):132-6. PubMed ID: 17601420
[TBL] [Abstract][Full Text] [Related]
10. Treatment of psoriasis with alefacept: correlation of clinical improvement with reductions of memory T-cell counts.
Gordon KB; Vaishnaw AK; O'Gorman J; Haney J; Menter A;
Arch Dermatol; 2003 Dec; 139(12):1563-70. PubMed ID: 14676071
[TBL] [Abstract][Full Text] [Related]
11. Treatment of psoriasis with alefacept in patients with hepatitis C infection: a report of two cases.
Thaçi D; Pätzold S; Kaufmann R; Boehncke WH
Br J Dermatol; 2005 May; 152(5):1048-50. PubMed ID: 15888169
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of multiple courses of alefacept in patients with moderate to severe chronic plaque psoriasis.
Menter A; Cather JC; Baker D; Farber HF; Lebwohl M; Darif M
J Am Acad Dermatol; 2006 Jan; 54(1):61-3. PubMed ID: 16384756
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis.
Krueger GG; Papp KA; Stough DB; Loven KH; Gulliver WP; Ellis CN;
J Am Acad Dermatol; 2002 Dec; 47(6):821-33. PubMed ID: 12451365
[TBL] [Abstract][Full Text] [Related]
14. Alefacept: an expert review concerning the treatment of psoriasis.
Langley RG; Cherman AM; Gupta AK
Expert Opin Pharmacother; 2005 Oct; 6(13):2327-33. PubMed ID: 16218892
[TBL] [Abstract][Full Text] [Related]
15. Development and use of alefacept to treat psoriasis.
Krueger GG; Callis KP
J Am Acad Dermatol; 2003 Aug; 49(2 Suppl):S87-97. PubMed ID: 12894131
[TBL] [Abstract][Full Text] [Related]
16. Alefacept: a novel biologic in the treatment of psoriasis.
Liu CM; McKenna JK; Krueger GG
Drugs Today (Barc); 2004 Dec; 40(12):961-74. PubMed ID: 15645008
[TBL] [Abstract][Full Text] [Related]
17. Alefacept.
Frampton J; Wagstaff A
Am J Clin Dermatol; 2003; 4(4):277-86; discussion 287. PubMed ID: 12680805
[TBL] [Abstract][Full Text] [Related]
18. Clinical response to alefacept: results of a phase 3 study of intravenous administration of alefacept in patients with chronic plaque psoriasis.
Krueger GG
J Eur Acad Dermatol Venereol; 2003 Jul; 17 Suppl 2():17-24. PubMed ID: 12795771
[TBL] [Abstract][Full Text] [Related]
19. Alefacept: potential new therapy for patients with moderate-to-severe psoriasis.
Shukla VK
Issues Emerg Health Technol; 2003 Apr; (45):1-4. PubMed ID: 12680422
[TBL] [Abstract][Full Text] [Related]
20. Clinical response to alefacept: results of a phase 3 study of intramuscular administration of alefacept in patients with chronic plaque psoriasis.
Ortonne JP
J Eur Acad Dermatol Venereol; 2003 Jul; 17 Suppl 2():12-6. PubMed ID: 12795770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]